Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Conscious Millionaire Show

2569: Harry Massey: The Future of Health Tech Wearables and Entrepreneurship

21 Dec 2022

Description

Welcome to the Conscious Millionaire Show for entrepreneurs,  who want to create an abundant future for themselves and humanity. Heard by millions in 190 countries.  Do you want to put more money in the bank, create a powerful impact, and enjoy a purposeful life? This is the podcast for you! Join host, JV Crum III, as he goes inside the minds of Millionaire Entrepreneurs and World-Class Business Experts. Today's featured episode... Harry Massey: The Future of Health Tech Wearables and Entrepreneurship Harry Massey is the Founder of Exponential Health Innovations, a research and design company in the field of bioenergetics, Chairman of NES Health, the leading bioenergetic practitioner company, and CEO of Energy 4 Life. He is the Inventor of proprietary IP approved by the FDA including the miHealth device, infoceuticals, and the Bioenergetic WellNES System. He is also the writer/producer of The Living Matrix and other health documentary films. Like this Podcast? Get every episode delivered to you free!  Subscribe in iTunes Download Your Free Money-Making Gift Now... "Born to Make Millions" Hypnotic Audio - Click Here Now! Please help spread the word. Subscribing and leaving a review helps others find our podcast. Thanks so much! Inc Magazine "Top 13 Business Podcasts." Conscious Millionaire Network has over 3,000 episodes and millions of listeners in 190 countries. Join us as a regular listener to get money-making secrets on how you can grow your business and profits faster!

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.